Terns Pharmaceuticals Stock Options
| TERN Stock | USD 39.19 0.92 2.29% |
Terns Pharmaceuticals' latest option contracts expiring on March 20th 2026 are carrying combined implied volatility of 0.94 with a put-to-call open interest ratio of 0.88 over 20 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on March 20th 2026. The total put volume is at 225.
Open Interest Against March 20th 2026 Option Contracts
2026-03-20
The chart above shows Terns Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Terns Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Terns Pharmaceuticals' option, there is no secondary market available for investors to trade.
Terns Pharmaceuticals Maximum Pain Price Across 2026-03-20 Option Contracts
Max pain occurs when Terns Pharmaceuticals' market makers reach a net positive position across all Terns Pharmaceuticals' options at a strike price where option holders stand to lose the most money. By contrast, Terns Pharmaceuticals' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Terns Pharmaceuticals
Analyzing Terns Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Terns Pharmaceuticals regardless of its overall volatility. This is especially true when Terns Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Terns Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Terns Pharmaceuticals' stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Terns Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Terns Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Terns Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Terns Stock moves the wrong way.
Terns Pharmaceuticals In The Money Call Balance
When Terns Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Terns Pharmaceuticals stock is said to be in the money. When it comes to buying Terns Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Terns Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Terns Current Options Market Mood
Terns Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Terns Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Terns Pharmaceuticals' options investors are not very successful. Terns Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Terns contract
Base on the Rule 16, the options market is currently suggesting that Terns Pharmaceuticals will have an average daily up or down price movement of about 0.0588% per day over the life of the 2026-03-20 option contract. With Terns Pharmaceuticals trading at USD 39.19, that is roughly USD 0.023. If you think that the market is fully incorporating Terns Pharmaceuticals' daily price movement you should consider buying Terns Pharmaceuticals options at the current volatility level of 0.94%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Terns Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Terns calls. Remember, the seller must deliver Terns Pharmaceuticals stock to the call owner when a call is exercised.
Terns Pharmaceuticals Option Chain
When Terns Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Terns Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Terns Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Terns. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Terns. It also shows strike prices and maturity days for a Terns Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | TERN260320C00070000 | 0 | 70.0 | 0.0 - 4.9 | 4.9 | |
Call | TERN260320C00065000 | 0 | 65.0 | 0.0 - 4.9 | 4.9 | |
Call | TERN260320C00060000 | 0 | 60.0 | 0.0 - 4.9 | 4.9 | |
Call | TERN260320C00055000 | 0 | 55.0 | 0.0 - 4.9 | 4.9 | |
Call | TERN260320C00050000 | 20 | 50.0 | 0.3 - 4.9 | 2.71 | Out |
Call | TERN260320C00045000 | 1 | 45.0 | 2.2 - 6.0 | 4.5 | Out |
Call | TERN260320C00040000 | 1 | 40.0 | 3.5 - 8.3 | 6.5 | Out |
Call | TERN260320C00035000 | 0 | 35.0 | 6.5 - 11.0 | 6.5 | In |
Call | TERN260320C00030000 | 0 | 30.0 | 10.0 - 14.0 | 10.0 | In |
Call | TERN260320C00025000 | 20 | 25.0 | 14.0 - 18.0 | 16.5 | In |
Put | TERN260320P00070000 | 0 | 70.0 | 27.9 - 32.5 | 27.9 | In |
Put | TERN260320P00065000 | 0 | 65.0 | 23.5 - 28.0 | 23.5 | In |
Put | TERN260320P00060000 | 0 | 60.0 | 18.4 - 23.0 | 18.4 | In |
Put | TERN260320P00055000 | 0 | 55.0 | 14.5 - 19.0 | 14.5 | In |
Put | TERN260320P00050000 | 0 | 50.0 | 10.0 - 14.5 | 10.0 | In |
Put | TERN260320P00045000 | 1 | 45.0 | 6.6 - 11.0 | 7.51 | In |
Put | TERN260320P00040000 | 0 | 40.0 | 3.2 - 7.9 | 3.2 | |
Put | TERN260320P00035000 | 6 | 35.0 | 1.0 - 4.9 | 3.2 | Out |
Put | TERN260320P00030000 | 0 | 30.0 | 0.35 - 2.6 | 0.35 | |
Put | TERN260320P00025000 | 30 | 25.0 | 0.3 - 1.3 | 1.55 | Out |
Terns Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Terns Total Stockholder Equity
Total Stockholder Equity |
|
Terns Pharmaceuticals Corporate Management
| David Strauss | VP Controller | Profile | |
| Pamela Danagher | Senior Assurance | Profile | |
| Debra Sieminski | Senior Affairs | Profile | |
| Jeffrey Jasper | Senior Research | Profile | |
| JD Esq | Chief Officer | Profile | |
| Senthil Sundaram | CEO Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Terns Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.